Overall rank by patents
#47,424
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
HVR Cardio Oy
USPTO PatentsView assignee record - 5 granted patents across 1 technology areas, active 2023–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
5
Total patents granted
1
CPC technology areas
16.2
Avg claims per patent
-
5-year filing velocity
The verdict
HVR holds 5 US patents across 1 technology areas, rank #47,424 of 50,000 tracked assignees.
- #47,424
- of 50,000 US assignees by volume
- Top 38%
- by Innovation Score (39.4/100)
- 16.2
- avg claims per patent
Portfolio overview
HVR Cardio Oy has been granted 5 US utility patents between 2023 and 2024, placing HVR Cardio Oy at rank #47,424 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, HVR Cardio Oy is one of the more focused assignees in the PatentsView dataset. By volume, HVR sits between Hunter Associates Laboratory, Inc. (5 patents, rank #47,420) and Hydrogenious LOHC Technologies Gmbh (5 patents, rank #47,428) - the closest US assignees by grant volume. The composite Innovation Score of 39.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2024, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. HVR Cardio Oy's 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark HVR Cardio Oy against peers pursuing similar technology classes.
Who files at HVR's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Hunter Associates…
HUNTER ASSOCIATES LABORATORY, INC.
5 patents
- Huntsman Australi…
HUNTSMAN CORPORATION AUSTRALIA Pty Limited
5 patents
- Hurst Internation…
HURST INTERNATIONAL, LLC
5 patents
- Hutom
HUTOM INC.
5 patents
- HWB
HWB, LLC
5 patents
- Hybrigenics
HYBRIGENICS S.A.
5 patents
- Hydramotion
HYDRAMOTION LIMITED
5 patents
- Hydrogenious LOHC
HYDROGENIOUS LOHC TECHNOLOGIES GMBH
5 patents
- HVR Cardio Oy ◀
HVR Cardio Oy
5 patents
What this shows HVR holds 5 patents at rank #47,424, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near HVR
By rank, the assignees closest to #47,424 in granted patent volume.
- Hunter Associates Laboratory, Inc. #47,420 · 5 patents
- Huntsman Corporation Australia Pty Limited #47,421 · 5 patents
- Hurst International, Llc #47,422 · 5 patents
- Hutom Inc. #47,423 · 5 patents
- HWB, Llc #47,425 · 5 patents
- Hybrigenics S.a. #47,426 · 5 patents
- Hydramotion Limited #47,427 · 5 patents
- Hydrogenious LOHC Technologies Gmbh #47,428 · 5 patents
Leaders in A61F (Filters Implantable INTO Blood Vessels)
Other assignees with the most granted patents in HVR's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- Depuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- COOK Medical Technologies Llc 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien Lp 528 in class
HVR's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 38% higher than 62% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 3 | 60.0% |
| 2024 | 2 | 40.0% |
Which technologies does HVR Cardio Oy patent most?
Top 1 of 1 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Standard
Frequently Asked Questions
How many patents does HVR Cardio Oy hold?
HVR Cardio Oy holds 5 US granted patents filed between 2023 and 2024, spanning 1 technology areas.
What is HVR Cardio Oy's Innovation Score?
HVR Cardio Oy has an Innovation Score of 39.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does HVR Cardio Oy focus on?
HVR Cardio Oy's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 5 patents. The company has filed patents in 1 CPC subclasses total.
Is HVR Cardio Oy's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for HVR Cardio Oy.
What does claim depth mean for HVR Cardio Oy's patents?
HVR Cardio Oy's patents average 16.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the HVR Cardio Oy patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
HVR's 5 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - HVR ranks #47,424 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.